chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received the Moderna COVID-19 vaccine for their first dose on 30Dec2020 and then the Pfizer COVID-19 vaccine for their second dose on 21Jan2021/ vaccine mix-up; A spontaneous report was received from a consumer concerning a 57-years-old, female patient who received Moderna's COVID-19 Vaccine, and received the Moderna COVID-19 vaccine for their first dose on 30Dec2020 and then the Pfizer COVID-19 vaccine for their second dose on 21Jan2021/ vaccine mix-up (wrong product administered).  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 30-Dec-2020, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number 025J20-2A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 30-Dec-2020, patient received the Moderna COVID-19 vaccine for their first dose and then the Pfizer COVID-19 vaccine for their second dose on 21-Jan-2021. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the event received the Moderna COVID-19 vaccine for their first dose on 30Dec2020 and then the Pfizer COVID-19 vaccine for their second dose on 21Jan2021/ vaccine mix-up (wrong product administered) was not provided.; Reporter's Comments: This report refers to a case of wrong product administered for mRNA-1273. There were no reported AEs associated with this case.
Approximately 36 hours after receiving the 2nd dose of the Moderna Covid19 vaccine, I came down with Shingles.  Symptoms started with a sharp pain in my back left side rib area, followed later in the day by spots starting to form, then over the next 24-48 hours a medium sized band of Shingles rashes has spread to cover left torso from back to stomach area.  Soreness, pain and itching standard to Shingles have been experienced.  Pain is bearable but one or two nights made it difficult to sleep.  The shingles seem to be progressing as they should and they have stopped spreading after a week.  Just wanted to identify a possible link to the Moderna shot causing Shingles.  Maybe if enough reports come in, a recommendation for 50+ year olds would be to get the Shingles vaccine first then get the Covid19 shot.
Extreme fatigue, pain in the arm, then swelling in the area around eyes, red-eye, and swollen red eyelids, then the onset of rapid heart rate, difficulty breathing, extreme exhaustion, and low energy first onset of massive grand mal seizure occurred approximately 24 hours after injection.
Approximately five minutes after receiving the vaccine, the patient began to lose consciousness (fainted) while sitting upright in a chair. The patient lost vision, then hearing, then eventually laid down on the floor until she regained consciousness.
fever 105 on Sunday 2 days p/vax MD in ER prescribed Augmentin;pt seem fussy/irritable;immunization rxn vs viral synd;
2" x 4" rash at site of injection x 4 days and intense headache 4 days after injection of vaccine.
Patient reports feeling dizzy and having shortness of breath. Reports that she is usually anxious after receiving shots. Cleared by EMS
I was dizzy this morning; sweating at night time; literally this morning I thought I was going to die; chills; I've had fever; my lymph nodes are very enlarged and tender; when I bring my hand up they are very enlarged and very tender; injection site tender; my lymph nodes are very enlarged and tender; when I bring my hand up they are very enlarged and very tender; whole body hurts; my head hurts; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I was dizzy this morning), HYPERHIDROSIS (sweating at night time), VACCINATION COMPLICATION (literally this morning I thought I was going to die), CHILLS (chills) and PYREXIA (I've had fever) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIZZINESS (I was dizzy this morning), HYPERHIDROSIS (sweating at night time), VACCINATION COMPLICATION (literally this morning I thought I was going to die), CHILLS (chills), PYREXIA (I've had fever), LYMPHADENOPATHY (my lymph nodes are very enlarged and tender; when I bring my hand up they are very enlarged and very tender), VACCINATION SITE PAIN (injection site tender), LYMPH NODE PAIN (my lymph nodes are very enlarged and tender; when I bring my hand up they are very enlarged and very tender), MYALGIA (whole body hurts) and HEADACHE (my head hurts). At the time of the report, DIZZINESS (I was dizzy this morning), HYPERHIDROSIS (sweating at night time), VACCINATION COMPLICATION (literally this morning I thought I was going to die), CHILLS (chills), PYREXIA (I've had fever), LYMPHADENOPATHY (my lymph nodes are very enlarged and tender; when I bring my hand up they are very enlarged and very tender), VACCINATION SITE PAIN (injection site tender) and LYMPH NODE PAIN (my lymph nodes are very enlarged and tender; when I bring my hand up they are very enlarged and very tender) outcome was unknown and MYALGIA (whole body hurts) and HEADACHE (my head hurts) had not resolved.            No concomitant medications were provided by the reported.  Treatment information was not reported.
Pt broke out with acute shingles/Varicella Zoster on his left abdomen and left posterior thorax as of 9-27-20, 10 days after receiving his 1st Shingrix vaccine.  Pt had a vessicular rash on erythematous base starting left of spine and ending left center of abdomen in line with T-11 and T-12 dermatomes
I21.4 ACUTE NON ST ELEVATION MI 5/11/2023 ACUTE NON ST ELEVATION MI I26.99 ACUTE PULMONARY EMBOLISM 5/11/2023 ACUTE NON ST ELEVATION MI
This is a spontaneous report from a contactable consumer or other non-health care professional. A 63-year-old female patient received second dose of BNT162B2 (COVID-19 VACCINE, Solution for injection, Lot number  and Expiration date was not reported), via an unspecified route of administration on 25May2021 (at the age of 63-years-old) as single dose for Covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient also received first dose of BNT162B2 (COVID-19 VACCINE , Solution for injection, Lot number and Expiration date was not reported). On an unspecified date the patient had experienced swelling and hotness at injection site. The patient stated that the swelling was in the size of a marble and has been larger and growing. She is asking if this is normal. The outcome of events was unknown. Information about batch/ lot number has been requested.
1 days p/vax pt devel an inj site rxn characterized by swelling, induration & redness which extended to the elbow, & fever of 101.5;this is one of two pt from this site;addtl info recv 17JUL96 indicated pt also exp myalgia & runny nose;
Seizure occurred at 12:30pm, lasted approximately 5 minutes. Parents reported that baby had been fed and was sleeping in mom's arms. Mom noticed the lips starting to quiver followed by jaws clenching and eyes flying open. Baby was not aware and not focused on mom or dad. Glassy eyed. Shortly after this, the whole body started shaking and was very stiff. Mom called 911 and dad held the baby. After a few minutes the episode was over and baby's body turned limp. She didn't move for another few minutes. Movements started again in hands, then arms and legs and later whole body. At this time EMS had arrived and they brought baby to the hospital. There was never a fever.
Got the vaccine at the request of friends, family, work colleagues and in preparation for a work conference. Two days later (after first shot), heart / chest pain begin. Pain continues and has not stopped. Now interfering with my mental and physical health, social life, and causing financial burden due to medical bills.
Injection site reaction - redness greater than the size of a quarter, itching,  sensation of being pricked around the site, injection site pain
Pt experienced upper extremity/shoulder/elbow arthralgia. Progressively worsened since start of Anthrax series (9/23/98).  Follow up 06/05/2000: "Patient did not recover from adverse event.  Shoulders ache; both elbows and muscles in arms hurt especially with exertion.  Left arm more than right."
Patient reported itching on head within 15 minutes of vaccination.  Given Benedryl.  Symptoms improved and patient was released to home.
Initial information received on 08-Mar-2019 regarding an unsolicited valid non-serious case received from a consumer. This case involves a female patient (age unknown) who experienced itchy rash that started at the injection site and then went down her arms to her hands and up to her neck and over to her chest, then the rash spread to the right arm and down to the right hand and gray spots on brown skin, while she received vaccine FLUZONE HIGH DOSE. The patient's past vaccination(s) included was INFLUENZA VACCINE. The patient's past medical history, medical treatment(s) and family history were not provided. On 08-Oct-2018, the patient received a 0.5ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE batch number: U1994AB, expiration date: 30-Apr-2019 via intramuscular route in the left deltoid. On an unknown date, the patient experienced a non-serious itchy rash that started at the injection site and then went down her arms to her hands and up to her neck and over to her chest, then the rash spread to the right arm and down to the right hand (rash pruritic) (vaccination site reaction) and gray spots on brown skin (skin pigmentation), a couple of hours later following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. (Other relevant tests included no lab data.) Final diagnosis was gray spots on brown skin and itchy rash that started at the injection site and then went down her arms to her hands and up to her neck and over to her chest, then the rash spread to the right arm and down to the right hand. The patient was treated with 10mg PREDNISONE, 0.1percent TRIAMCINOLONE ACETONIDE and Tacrolimus 0.1% ointment. The patient outcome was not reported for all the events. List of documents held by sender: none.
Information has been received from a nurse concerning a female child who on an unspecified date was vaccinated with measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) . (lot not reported). The nurse reported that the mother indicated that the child had diarrhea for a year. The nurse also reported that the vaccine was administered at another practice. Unspecified medical attention was sought. Outcome of diarrhea was unk. Additional information has been requested.
18-year-old active male with supraclavicular lymphadenopathy to the left side x 4 days, smallpox vaccination on 29 January 2020 on ipsilateral shoulder. 3 nodules approximately 1 cm each at supraclavicular region, they are nontender, rubbery and mobile.  No axillary lymphadenopathy noted on exam and patient has a otherwise benign physical exam. Per  NOVEMBER 2010 article , will monitor for 4 weeks.
Approximately 36 hours after receiving the dose the patient started experiencing nausea that got quite severe at one point. She never vomited. She also developed a fever and the injection site was warm to touch, fever never got above 100 degrees F. The injection site was NOT red or swollen. She also developed body aches and fatigue. Symptoms lasted about 3 days. She used ibuprofen for fever and body aches. Symptoms have resolved.
Pfizer 9/22 and 10/13. Positive on 12/15
8 days p/vax 16MAR95 evening pt started w/fever, fussy & crying during that noc; 530AM 17MAR95 pt awake & had 1 convuls lasting 1 min; seen by MD; dx febrile seizure; t102; blood test nl; devel measles rash lasting 2-3 days;
One week after being given the vaccine on Monday, January 4, 2021, my upper left arm has turned red, swollen, hot and itchy. This has now lasted 8 days after first noticing site area reaction  and 2 weeks after vaccine given. I saw the doctor on Monday, January 18 and he recommended Benadryl every 4 to 6 hours. He also wanted me to report the site reaction and get your advice on receiving the 2nd vaccine.
Patient very clumsy when learning to walk, noticed her eyes would not line up at times. We took her to an eye surgeon who discovered monocular elevation deficiency of R eye. This was not present at birth and became noticeable in June 2016.   Surgeon believes she will need surgery to attempt to fix, but there is a possibility that it may not be reversed. We choose to try vision therapy first.
bleeding started,heavy period,; hot flashes; hot flashes increased; back hurts; itchy in eyes; confused; feels depressed; anxiety increased; small rash; body aches; had headaches; was tired; swollen hands; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts) and EYE PRURITUS (itchy in eyes) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CIMICIFUGA RACEMOSA ROOT, GLYCINE MAX EXTRACT (BLACK COHOSH & SOY ISOFLAVONES), ESTRADIOL, CLOBETASOL PROPIONATE, LORAZEPAM and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PERIPHERAL SWELLING (swollen hands). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts), EYE PRURITUS (itchy in eyes), CONFUSIONAL STATE (confused), DEPRESSION (feels depressed), ANXIETY (anxiety increased), RASH (small rash), PAIN (body aches), HEADACHE (had headaches) and FATIGUE (was tired). At the time of the report, HEAVY MENSTRUAL BLEEDING (bleeding started,heavy period,), HOT FLUSH (hot flashes), HOT FLUSH (hot flashes increased), BACK PAIN (back hurts), EYE PRURITUS (itchy in eyes), CONFUSIONAL STATE (confused), PERIPHERAL SWELLING (swollen hands), DEPRESSION (feels depressed), ANXIETY (anxiety increased), RASH (small rash), PAIN (body aches), HEADACHE (had headaches) and FATIGUE (was tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no treatment drugs were provided.   This case was linked to MOD-2021-076311 (Patient Link).
face appeared red (sunburned) appearance @ 530PM on 6APR98;7APR98 @ 815AM;mom noticed rash-red blotches w/induration size smaller than end of pencil eraser w/some itching;rash is on the arms, legs, stomach back & face;
Severe body aches in all joints; This is a spontaneous report from a contactable healthcare professional from a Pfizer-sponsored program. A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as 1st dose, single for COVID-19 immunization; and tofacitinib citrate (XELJANZ XR, 11 mg Prolonged-release tablet), oral from 09Sep2020 and ongoing, at 11 mg, 1x/day for rheumatoid arthritis. Medical history and concomitant medications were not reported. The patient experienced severe body aches in all joints on an unspecified date, which lasted a few days and resolved. The action taken in response to the event for tofacitinib citrate was unknown. The outcome of the event was resolved on an unspecified date.   No follow-up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.
Friend of mom called 2JUL91 saying child had poss rxn to DTP; mom said child cried w/arm 26JUN91, much of noc had redness around inject site, started crying w/ h/a & inc fever, diarrhea; Taken to MD who felt was virus;
The second vaccine, developed body aches but no fever or rash after 48hours. The patient took tylenol with positive results.
A nurse reported the occurrence of injection site redness in a 6 year old male who was vaccinated with Infanrix for prophylaxis. The vacicnee's medical history included unspecified allergies. The vaccinee had no adverse experiences following receipt of prior immunizations. There were no concurrent medications. On 8/14/02, the vaccinee received on injection of Infanrix (526E9); the number of previous injections of Infanrix was not reported. One day post-immunization, on 8/15/02, the vaccinee developed an area of redness at the injection site measuring 10cm by 5cm. He was seen by the physician, who prescribed Zyrtec. As of 8/16/02, the outcome of this event was unknown. The reporting nurse indicated that an additional vaccinee experienced this event; however, that subject is currently not identifiable.
1:30AM - Fever and Chills 5:00AM - Fever and Chills + Muscle Fatigue 7:00AM - Muscle Fatigue and Severe Headache 10:00AM  - Muscle Fatigue and Severe Headache 12PM - Muscle Fatigue and Headache diminished after taking (3) Ibuprofen and (3) Excedrin Migraine at 10:00AM
Reaction result of a vaccine. Common reaction for vaccine as per primary care note on 5/15/14. Local warmth, tenderness and pain; swelling.
Polymyalgia Rheumatica prednisone 15 mg/d - started 10/9/12.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age. On an unknown date the patient was inadvertently vaccinated with a dose of VARIVAX (merck) (lot number unspecified) instead of ZOSTAVAX due to nursing error. No adverse effect reported. It was unknown if the patient had sought medical attention. This is one of several reports received from same source. Additional information has been requested.
Very hot, but skin cold and clammy to touch. 7/2-joints very stiff all over, injection site very hot, swollen, sore. Additional congestion in chest. Continued feeling bad. 7/6 injection site red, swollen and red welts going around the arm and down in side underarms and left side of body.
redness, itching and rash on arm 2 weeks after 1st dose; redness, itching and rash on arm 2 weeks after 1st dose; redness, itching and rash on arm 2 weeks after 1st dose; A spontaneous report was received from a type concerning a 76-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness, itching and rash on arm 2 weeks after 1st dose.  The patient's medical history was not provided. Concomitant medications reported were tamoxifen, latanoprost, timolol, levothyroxine, crestor, baby aspirin, coenzyme q10, lisinopril, vitamin d, omega-3, proair for drug use for unknown indication.  On 13 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 011mz0a) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) redness, itching and rash on arm 2 weeks after 1st dose.  Treatment details included Benadryl.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), redness, itching and rash on arm 2 weeks after 1st dose was unknown.
Dizziness, Myalgia, Arthralgia, fatigue, bruising Narrative:
Loss of appetite; Various muscle pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), MYALGIA (Various muscle pain) and FATIGUE (Fatigue) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite), MYALGIA (Various muscle pain) and FATIGUE (Fatigue). At the time of the report, DECREASED APPETITE (Loss of appetite), MYALGIA (Various muscle pain) and FATIGUE (Fatigue) had not resolved. Not Provided          No concurrent and treatment medication was reported by patient.  Patient wanted to know that vaccination ID and need to know that those were correct and valid or not.
Noticed the next day after the vaccination my arm was sore, then itching with hives. Took Benadryl and put some cortisone on it to stop the itching.
He had the second shot, had very mild headache, and then woke up approx 48 hours after 2nd dose, complaining that his " chest hurt", I asked him to explain the " hurt", he said his chest felt tight, heavy pressure, like weight on his chest, uncomfortable. He said it went away after a few days... I didn't realize the inflammation of the heart was a side affect, until I recently heard that was coming up, so I put 2 and 2 together, and thought I had better report.
Patient called 06-28-2005 stating her tongue was swollen.  She sought no medical treatment.  I spoke with patient on 6-30-2005; she stated in retrospect that there was some circumoral itching on 06-25-05 and then left facial and mouth swelling.  She took a Benadryl and the symptoms resolved.
HEADACHE; FEVER; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021 07:00, the subject experienced headache. On 11-MAR-2021 07:00, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, and had not recovered from headache. This report was non-serious.
Patient is noticed to have generalized weakness, holding his head towards right side, mild right facial puffiness with mild left facial droop, and sent to ER, on 1/22/21. Patient also had mild fever for the last two days and was on Tylenol, blood pressure also remained elevated moderately than the usual readings. Patient was admitted through ER for 2 days and was discharged on 1/24/21, with a diagnosis of possible TIA, Todd's paresis post seizure. Patient's CT head and MRI of brain was negative for acute stroke. Patient's left facial droop and right side facial puffiness resolved over a week but noticed to have right sided pronounced weakness with moderate swelling on right arm. Patient used to eat by himself,but now not able to do so and not able to hold cup in the right hand. Patient was again sent to ER for repeat CAT scan of head, further evaluation and management. Not sure if patient had an adverse reaction to Covid-19 vaccination, but definitely these symptoms were developed after 2 weeks of receiving Pfizer vaccination, which may be coincidental. Patient was followed up by the neurologist a week after the discharge from hospital who couldn't rule out adverse reaction of vaccination. Patient is awaiting for an EEG, carotid ultrasound and Echo as an out patient.
2nd dose Covid Moderna  4/19/21 lot#: 036B21A   started with an itchy left ear, postherpetic neuralgia on right side of head, paralyzed right face, vertigo can't handle. Trouble closing my eye, feel unsteady to walk and one year unable to work.
Deep Vein Thrombosis(DVT) occurred after 4-5 weeks of second COVID-19 vaccine dose.